Lilly Revenue Guidance Rises Along With Diabetes, Obesity Investments

Oral GLP-1, Injectable GGG Agonists Moving Into Phase III

 
• By Mandy Jackson
  
Lilly Corporate Center Indianapolis
Lilly will launch four products in 2023 and may gain a weight loss indication for Mounjaro • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip